FRANCIS KNUETTEL II (Interim CEO, CFO, Treas & Sec) purchased 1.0% of their position (5.20K shares) of PELTHOS THERAPEUTICS INC. on the open market
Open‑market purchase worth $5.0K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 9/16/2024ACC: 0001753926-24-001576
Officer· Interim CEO, CFO, Treas & Sec
Since Feb 2024
+5.20K
Net shares
Net buyer
$5.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
5.20K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+1.70K
Price / share
$0.97
Trade value
$1.65K
% of position
0.3%
9/12/2024
542.51K→544.21K
Common Stock
Indirect
Shares
+3.50K
Price / share
$0.97
Trade value
$3.40K
% of position
0.6%
9/13/2024
544.21K→547.71K
Total
Net shares
+5.20K
Net value
$5.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/12/2024 | P · Purchase | +1.70K | $0.97 | $1.65K | 0.3% | 542.51K | 544.21K |
| Common Stock Indirect | 9/13/2024 | P · Purchase | +3.50K | $0.97 | $3.40K | 0.6% | 544.21K | 547.71K |
| Total | +5.20K | $5.04K | ||||||
Derivative Transactions0
No derivative transactions reported